ATE264328T1 - Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen - Google Patents

Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen

Info

Publication number
ATE264328T1
ATE264328T1 AT00926043T AT00926043T ATE264328T1 AT E264328 T1 ATE264328 T1 AT E264328T1 AT 00926043 T AT00926043 T AT 00926043T AT 00926043 T AT00926043 T AT 00926043T AT E264328 T1 ATE264328 T1 AT E264328T1
Authority
AT
Austria
Prior art keywords
naphthhyridine
cyano
inhibitors
substituted
tyrosine kinases
Prior art date
Application number
AT00926043T
Other languages
English (en)
Inventor
Allan Wissner
Philip Ross Hamann
Ayako Yamashita
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE264328T1 publication Critical patent/ATE264328T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00926043T 1999-04-21 2000-04-18 Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen ATE264328T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29550799A 1999-04-21 1999-04-21
PCT/US2000/010250 WO2000066583A1 (en) 1999-04-21 2000-04-18 Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases

Publications (1)

Publication Number Publication Date
ATE264328T1 true ATE264328T1 (de) 2004-04-15

Family

ID=23138006

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00926043T ATE264328T1 (de) 1999-04-21 2000-04-18 Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen

Country Status (23)

Country Link
EP (1) EP1171440B1 (de)
JP (1) JP2002543198A (de)
KR (1) KR20020002433A (de)
CN (1) CN100408576C (de)
AR (1) AR029880A1 (de)
AT (1) ATE264328T1 (de)
AU (1) AU776962B2 (de)
BR (1) BR0009870A (de)
CA (1) CA2365212A1 (de)
CZ (1) CZ20013660A3 (de)
DE (1) DE60009888T2 (de)
DK (1) DK1171440T3 (de)
ES (1) ES2216884T3 (de)
HK (1) HK1040077B (de)
HU (1) HUP0200816A3 (de)
IL (1) IL145870A0 (de)
NO (1) NO20015062D0 (de)
NZ (1) NZ514576A (de)
PL (1) PL350920A1 (de)
PT (1) PT1171440E (de)
RU (1) RU2001131356A (de)
WO (1) WO2000066583A1 (de)
ZA (1) ZA200108015B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2003002287A1 (es) * 2002-11-25 2005-01-14 Wyeth Corp COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
US7276519B2 (en) * 2002-11-25 2007-10-02 Wyeth Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
EP2543376A1 (de) 2004-04-08 2013-01-09 Targegen, Inc. Benzotriazin Kinasehemmer
MX2007014258A (es) * 2005-05-18 2008-01-22 Wyeth Corp Inhibidores de 4,6-diamino-[1,7]naftiridin-3-carbonitrilo de la tpl2 cinasa y metodos de fabricacion y uso de los mismos.
JP5191391B2 (ja) 2005-11-01 2013-05-08 ターゲジェン インコーポレーティッド キナーゼのビ−アリールメタ−ピリミジン阻害剤
RS52298B (sr) 2006-01-31 2012-12-31 Array Biopharma Inc. Inhibitori kinaze i postupak njihove upotrebe
ES2301380B1 (es) * 2006-08-09 2009-06-08 Laboratorios Almirall S.A. Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es) 2007-03-02 2010-03-16 Laboratorios Almirall S.A. Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es) 2007-04-26 2010-09-23 Laboratorios Almirall S.A. Nuevos derivados de 4,8-difenilpoliazanaftaleno.
EP2108641A1 (de) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. Neue substituierte Spiro[Cycloalkyl-1,3'-indo]-2'(1'H)-on-Derivate und ihre Verwendung als p38 mitogen-activated Kinase Inhibitoren
EP2113503A1 (de) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. Neue substituierte Indolin-2-on- Derivate und ihre Verwendung als p39 mitogen-activated Kinase Inhibitoren
CN102625799A (zh) * 2009-06-25 2012-08-01 安姆根有限公司 杂环化合物及其用途
EP2332939A1 (de) 2009-11-26 2011-06-15 Æterna Zentaris GmbH Neuartige Naphthyridinderivate und ihre Verwendung als Kinasehemmer
AU2010363329A1 (en) 2010-11-07 2013-05-09 Targegen, Inc. Compositions and methods for treating myelofibrosis
CN102675311A (zh) * 2011-06-14 2012-09-19 苏春华 一种氟代丙烯酰胺的衍生物
EP2809652B1 (de) 2012-01-30 2019-05-15 F.Hoffmann-La Roche Ag Isochinolin- und naphthyridinderivate
UY35772A (es) 2013-10-14 2015-05-29 Bayer Cropscience Ag Nuevos compuestos plaguicidas
SG11201805286RA (en) * 2015-12-24 2018-07-30 Kyowa Hakko Kirin Co Ltd α,β-UNSATURATED AMIDE COMPOUND
CN107556309B (zh) * 2017-09-11 2020-12-01 浙江永宁药业股份有限公司 多取代四氢萘啶类化合物的药物用途及其制备方法
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
WO1998013350A1 (en) * 1996-09-25 1998-04-02 Zeneca Limited Qinoline derivatives inhibiting the effect of growth factors such as vegf
UA73073C2 (uk) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
TW436485B (en) * 1997-08-01 2001-05-28 American Cyanamid Co Substituted quinazoline derivatives

Also Published As

Publication number Publication date
NZ514576A (en) 2004-02-27
BR0009870A (pt) 2002-01-08
DE60009888T2 (de) 2005-04-21
AU4463900A (en) 2000-11-17
DE60009888D1 (de) 2004-05-19
CZ20013660A3 (cs) 2002-01-16
AR029880A1 (es) 2003-07-23
HUP0200816A3 (en) 2003-06-30
PT1171440E (pt) 2004-07-30
EP1171440B1 (de) 2004-04-14
HUP0200816A2 (en) 2002-08-28
AU776962B2 (en) 2004-09-30
RU2001131356A (ru) 2003-06-27
PL350920A1 (en) 2003-02-10
HK1040077A1 (en) 2002-05-24
DK1171440T3 (da) 2004-08-02
WO2000066583A1 (en) 2000-11-09
HK1040077B (en) 2004-09-10
CA2365212A1 (en) 2000-11-09
NO20015062L (no) 2001-10-18
EP1171440A1 (de) 2002-01-16
JP2002543198A (ja) 2002-12-17
ZA200108015B (en) 2003-03-26
CN1347416A (zh) 2002-05-01
IL145870A0 (en) 2002-07-25
KR20020002433A (ko) 2002-01-09
CN100408576C (zh) 2008-08-06
NO20015062D0 (no) 2001-10-18
ES2216884T3 (es) 2004-11-01

Similar Documents

Publication Publication Date Title
ATE264328T1 (de) Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen
NO20000487D0 (no) Substituerte quinazolinderivater og anvendelse derav som tyrosin kinase inhibitorer
ATE286045T1 (de) Tyrosin kinaseinhibitoren
CY2014034I1 (el) Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης
ATE255575T1 (de) Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren
FR13C0003I2 (fr) Inhibiteurs cycliques de proteine tyrosine kinase
EP1161433A4 (de) Tyrosin-kinase-inhibitoren
DE60021423D1 (de) 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren
IS5093A (is) Kínólín og kínasólín efnasambönd nytsamleg í meðferð, einkum til að meðhöndla góðkynja vefjaauka í blöðruhálskirtli
ATE344241T1 (de) Benzyliden-1,3-dihydro-indol-2-on-derivate als inhibitoren von rezeptor tyrosine kinasesn, insbesondere von raf kinasen
NO20012583D0 (no) Quinoliner og quinoksalinforbindelser som PDGF-R- og/eller LCK-tyrosinkinase-inhibitorer
DK0912559T3 (da) Kondenserede heterocykliske forbindelser som proteintyrosinkinaseinhibitorer
DK0986382T3 (da) RAF-kinasehæmmere
NO20002166L (no) Anvendelse av quinazolinderivater som tyrosinkinaseinhibitorer for behandling av kolonpolypper
ZA9810219B (en) Benzothiazole protein tyrosine kinase inhibitors.
ATE288424T1 (de) Diaminothiazole und ihre verwendung zur inhibierung von proteinkinasen
DE60001735D1 (de) 1-aminotriazolo 4,3-a chinazolin-5-one und/oder -thione inhibitoren von phosphodiesterasen iv
ATE387448T1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
FI955661A7 (fi) Substituoidut beta-aryyli- ja beta-heteroaryyli-alfa-syanoakryyliamidi johdannaiset tyrosiinikinaasi-inhibiittoreina
DE60008353D1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
ATE253059T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1171440

Country of ref document: EP

REN Ceased due to non-payment of the annual fee